X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3151) 3151
science & technology (2431) 2431
life sciences & biomedicine (2280) 2280
nasopharyngeal carcinoma (1884) 1884
male (1848) 1848
nasopharyngeal neoplasms - drug therapy (1731) 1731
female (1675) 1675
oncology (1531) 1531
middle aged (1448) 1448
nasopharyngeal neoplasms - pathology (1415) 1415
adult (1336) 1336
carcinoma (1149) 1149
nasopharyngeal neoplasms - radiotherapy (1081) 1081
aged (987) 987
cancer (973) 973
cell line, tumor (697) 697
chemotherapy (677) 677
radiotherapy (612) 612
prognosis (576) 576
antineoplastic combined chemotherapy protocols - therapeutic use (559) 559
adolescent (532) 532
treatment outcome (528) 528
neoplasm staging (518) 518
animals (513) 513
nasopharyngeal cancer (512) 512
combined modality therapy (504) 504
nasopharyngeal neoplasms - metabolism (494) 494
nasopharyngeal neoplasms - therapy (485) 485
care and treatment (464) 464
metastasis (441) 441
nasopharyngeal neoplasms - mortality (434) 434
radiation therapy (415) 415
nasopharyngeal neoplasms - genetics (403) 403
cisplatin - administration & dosage (393) 393
carcinoma - drug therapy (389) 389
mice (384) 384
apoptosis (381) 381
retrospective studies (379) 379
cancer therapies (347) 347
disease-free survival (321) 321
young adult (321) 321
carcinoma - pathology (312) 312
research (310) 310
follow-up studies (309) 309
survival rate (290) 290
apoptosis - drug effects (280) 280
tumors (280) 280
analysis (275) 275
health aspects (270) 270
antineoplastic agents - therapeutic use (268) 268
radiology, nuclear medicine & medical imaging (258) 258
otorhinolaryngology (251) 251
proteins (246) 246
carcinoma - radiotherapy (245) 245
mice, nude (244) 244
radiotherapy dosage (244) 244
fluorouracil - administration & dosage (240) 240
patients (240) 240
medical prognosis (239) 239
child (238) 238
survival analysis (238) 238
nasopharyngeal neoplasms - diagnosis (236) 236
cell proliferation - drug effects (230) 230
carcinoma, squamous cell - drug therapy (224) 224
stomatognathic diseases (223) 223
medicine (216) 216
antineoplastic agents - pharmacology (213) 213
chemotherapy, adjuvant (212) 212
cell biology (211) 211
gene expression (210) 210
research article (210) 210
neoplasm metastasis (208) 208
otorhinolaryngologic diseases (207) 207
cell proliferation (198) 198
cisplatin (197) 197
studies (193) 193
hematology, oncology and palliative medicine (192) 192
gene expression regulation, neoplastic (191) 191
medicine, research & experimental (188) 188
nasopharyngeal neoplasms - virology (188) 188
research & experimental medicine (188) 188
chemoradiotherapy (185) 185
neoplasms. tumors. oncology. including cancer and carcinogens (184) 184
drug therapy (181) 181
metastases (181) 181
development and progression (180) 180
abridged index medicus (176) 176
genetic aspects (172) 172
kaplan-meier estimate (167) 167
antineoplastic combined chemotherapy protocols - adverse effects (164) 164
aged, 80 and over (163) 163
risk factors (162) 162
cell cycle (159) 159
cisplatin - therapeutic use (158) 158
radiation (158) 158
pharmacology & pharmacy (156) 156
survival (154) 154
kinases (153) 153
medicine & public health (152) 152
mice, inbred balb c (152) 152
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3186) 3186
Chinese (163) 163
French (51) 51
German (39) 39
Japanese (27) 27
Russian (18) 18
Spanish (18) 18
Italian (15) 15
Polish (6) 6
Czech (5) 5
Portuguese (3) 3
Romanian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Croatian (1) 1
Danish (1) 1
Hebrew (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 5, pp. 1360 - 1368
... followed by chemoradiotherapy with intensity-modulated radiation therapy (C-IMRT) for head-and-neck cancer patients... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Volume changes | Chemo-IMRT | Dosimetric changes | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Laryngeal Neoplasms - radiotherapy | Prospective Studies | Humans | Oropharyngeal Neoplasms - diagnostic imaging | Spinal Cord - radiation effects | Laryngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - pathology | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - radiotherapy | Fluorouracil - administration & dosage | Time Factors | Laryngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - drug therapy | Brain Stem - radiation effects | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - drug therapy | Parotid Gland - diagnostic imaging | Head and Neck Neoplasms - diagnostic imaging | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Tumor Burden | Head and Neck Neoplasms - pathology | Radiography | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Parotid Gland - radiation effects | Hypopharyngeal Neoplasms - pathology | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Hypopharyngeal Neoplasms - diagnostic imaging | Care and treatment | Chemotherapy | Oncology, Experimental | Radiation | Research | Radiotherapy | Cancer | Index Medicus | TOMOGRAPHY | HEAD | DIAGNOSTIC TECHNIQUES | NEOPLASMS | RADIATION DOSES | MEDICINE | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | NUCLEAR MEDICINE | CAT SCANNING | DISEASES | THERAPY | DOSES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY | BODY | COMBINED THERAPY | RADIOLOGY
Journal Article
European archives of oto-rhino-laryngology, ISSN 0937-4477, 1/2005, Volume 262, Issue 1, pp. 1 - 7
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 12/2013, Volume 87, Issue 5, pp. 1086 - 1093
Purpose To assess the dosimetric benefit, treatment outcome, and toxicity of high-dose and extended-field intensity modulated radiation therapy (IMRT... 
Radiology | Hematology, Oncology and Palliative Medicine | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Organs at Risk - radiation effects | Pharyngeal Neoplasms - radiotherapy | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Pharyngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - pathology | Young Adult | Child | Radiotherapy Planning, Computer-Assisted | Lymphatic Irradiation - methods | Radiotherapy, Intensity-Modulated - mortality | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Nose Neoplasms - pathology | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Oropharyngeal Neoplasms - radiotherapy | Pharyngeal Neoplasms - diagnostic imaging | Pharyngeal Neoplasms - mortality | Radiography | Lymphoma, Extranodal NK-T-Cell - pathology | Parotid Gland - radiation effects | Adolescent | Organs at Risk - diagnostic imaging | Lymphoma, Extranodal NK-T-Cell - mortality | Pharyngeal Neoplasms - pathology | Xerostomia - etiology | Nasopharyngeal Neoplasms - mortality | Oropharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - mortality | Radiotherapy, Intensity-Modulated - adverse effects | Organ Sparing Treatments - methods | Nasopharyngeal Neoplasms - radiotherapy | Lymphoma, Extranodal NK-T-Cell - drug therapy | Lymphoma, Extranodal NK-T-Cell - radiotherapy | Nose Neoplasms - radiotherapy | Adult | Female | Lymphatic Irradiation - adverse effects | Retrospective Studies | Nasopharyngeal Neoplasms - drug therapy | Neck | Parotid Gland - diagnostic imaging | Neoplasm Invasiveness | Treatment Outcome | Xerostomia - prevention & control | Disease-Free Survival | Lymphoma, Extranodal NK-T-Cell - diagnostic imaging | Care and treatment | Lymphomas | Radiotherapy | Nuclear radiation | Patient outcomes | Index Medicus | LYMPHOMAS | GLANDS | LYMPH NODES | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | TOXICITY | RADIOTHERAPY | GY RANGE 10-100 | PLANNING
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 74, Issue 2, pp. 477 - 481
.... Radiotherapy was the primary local treatment modality for 8 patients. Results Of the 12 patients, 8 had died after a median follow-up of 13 months... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Small cell | Chemotherapy | Radiotherapy | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Laryngeal Neoplasms - radiotherapy | Nasopharyngeal Neoplasms - mortality | Humans | Middle Aged | Male | Carcinoma, Small Cell - mortality | Universities | Nasopharyngeal Neoplasms - radiotherapy | Nose Neoplasms - radiotherapy | Parotid Neoplasms - radiotherapy | Aged, 80 and over | Laryngeal Neoplasms - drug therapy | Female | Retrospective Studies | Nasopharyngeal Neoplasms - drug therapy | Carcinoma, Small Cell - drug therapy | Carcinoma, Small Cell - radiotherapy | Head and Neck Neoplasms - drug therapy | Florida | Tonsillar Neoplasms - mortality | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Laryngeal Neoplasms - mortality | Parotid Neoplasms - mortality | Tonsillar Neoplasms - radiotherapy | Nose Neoplasms - drug therapy | Tonsillar Neoplasms - drug therapy | Aged | Combined Modality Therapy - methods | Parotid Neoplasms - drug therapy | Head and Neck Neoplasms - mortality | Nose Neoplasms - mortality | Carcinoma | Universities and colleges | Cancer | Index Medicus | SURGERY | HEAD | PATIENTS | CAVITIES | FAILURES | LARYNX | LYMPHATIC SYSTEM | CHEMOTHERAPY | PHARYNX | SURVIVAL TIME | GLANDS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY
Journal Article
PloS one, ISSN 1932-6203, 11/2014, Volume 9, Issue 11, pp. e112581 - e112581
Background: Several inflammation-based prognostic scoring systems, including Glasgow Prognostic Score (GPS), neutrophil to lymphocyte ratio (NLR) and platelet... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Blood Platelets - pathology | Bone Neoplasms - mortality | Inflammation - pathology | Lung Neoplasms - drug therapy | Carcinoma | Nasopharyngeal Neoplasms - mortality | Prognosis | Area Under Curve | Lung Neoplasms - mortality | Cell Count | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Antineoplastic Agents - therapeutic use | Liver Neoplasms - mortality | Nasopharyngeal Neoplasms - pathology | Lung Neoplasms - secondary | Inflammation - drug therapy | Adult | Female | Retrospective Studies | Bone Neoplasms - drug therapy | Inflammation - diagnosis | Nasopharyngeal Neoplasms - drug therapy | Liver Neoplasms - secondary | Inflammation - mortality | Nasopharyngeal Neoplasms - diagnosis | Neutrophils - pathology | Nasopharyngeal Carcinoma | Bone Neoplasms - diagnosis | Liver Neoplasms - drug therapy | Proportional Hazards Models | Lymphocytes - pathology | Liver Neoplasms - diagnosis | Cisplatin - therapeutic use | Adolescent | Survival Analysis | Aged | Lung Neoplasms - diagnosis | Dehydrogenases | Demography | Laboratories | Colorectal cancer | Oncology | Metastasis | Family medical history | Cancer therapies | Metastases | Proteins | Nasopharyngeal carcinoma | Demographics | Lymphocytes | Mathematical models | Deoxyribonucleic acid--DNA | Cell survival | Neutrophils | Inflammation | Stability analysis | Regression analysis | Survival | Patients | Cisplatin | Esophagus | Chemotherapy | Hospitals | Medical prognosis | Resampling | Tumors | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 4, pp. 846 - 853
...) intensity modulated proton therapy (IMPT) for patients with head and neck tumors. Methods and Materials Fifteen consecutive patients with head and neck cancer underwent MFO-IMPT with active scanning beam proton therapy... 
Radiology | Hematology, Oncology and Palliative Medicine | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Uncertainty | Follow-Up Studies | Humans | Middle Aged | Proton Therapy - adverse effects | Male | Carcinoma, Squamous Cell - radiotherapy | Chemoradiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Tongue Neoplasms - drug therapy | Nasopharyngeal Neoplasms - radiotherapy | Adult | Female | Radiotherapy Setup Errors | Nasopharyngeal Neoplasms - drug therapy | Radiotherapy Planning, Computer-Assisted | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Carcinoma, Adenoid Cystic - drug therapy | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Stomatitis - etiology | Quality Assurance, Health Care | Head and Neck Neoplasms - radiotherapy | Pilot Projects | Carcinoma, Squamous Cell - drug therapy | Aged | Carcinoma, Adenoid Cystic - radiotherapy | Proton Therapy - methods | Xerostomia - etiology | Head and neck tumors | Sects | Care and treatment | Nuclear radiation | Index Medicus | HEAD | MEV RANGE 10-100 | PATIENTS | CLINICAL TRIALS | PROTON BEAMS | SKULL | TOXICITY | MEV RANGE 100-1000 | PLANNING | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | OPTIMIZATION | NECK | RADIOTHERAPY
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2008, Volume 70, Issue 3, pp. 660 - 665
Purpose To discuss the implications of three examples of periparotid recurrence after definitive intensity-modulated radiotherapy (IMRT... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Intensity-modulated radiotherapy | Nasopharyngeal cancer | Parotid recurrence | Oropharyngeal cancer | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Parotid Gland - surgery | Skin Neoplasms - radiotherapy | Humans | Middle Aged | Male | Tonsillar Neoplasms - diagnostic imaging | Carcinoma, Squamous Cell - diagnostic imaging | Carcinoma - diagnostic imaging | Carcinoma, Squamous Cell - radiotherapy | Nasopharyngeal Neoplasms - radiotherapy | Neoplasm Recurrence, Local - diagnostic imaging | Treatment Failure | Nasopharyngeal Neoplasms - drug therapy | Carcinoma - secondary | Carcinoma - drug therapy | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Head and Neck Neoplasms - diagnostic imaging | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Lymphatic Metastasis | Carcinoma - radiotherapy | Head and Neck Neoplasms - radiotherapy | Carcinoma, Squamous Cell - drug therapy | Radiation Injuries - prevention & control | Parotid Gland - radiation effects | Tonsillar Neoplasms - radiotherapy | Radionuclide Imaging | Skin Neoplasms - secondary | Tonsillar Neoplasms - drug therapy | Carcinoma, Squamous Cell - secondary | Radiotherapy | Nuclear radiation | Index Medicus | SURGERY | HEAD | PATIENTS | NEOPLASMS | LYMPH NODES | FAILURES | METASTASES | RADIATION DOSES | CHEMOTHERAPY | HEALTH HAZARDS | GLANDS | POSITRON COMPUTED TOMOGRAPHY | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY
Journal Article
Klinische Pädiatrie, ISSN 0300-8630, 11/2013, Volume 225, Issue 6, pp. 315 - 319
Abstract Background: Neuroendocrine neoplasms (NEN) in children are rare. In Germany, children with NEN of the gastroenteropancreatic system are prospectively registered since 1997... 
Original Article | Karzinoide | neuroendokrine Neoplasie | neuroendokrine Karzinome | neuroendokrine Tumoren | Life Sciences & Biomedicine | Pediatrics | Science & Technology | Lung Neoplasms - drug therapy | Nasopharyngeal Neoplasms - mortality | Gastrointestinal Neoplasms - drug therapy | Gastrointestinal Neoplasms - mortality | Lung Neoplasms - mortality | Pancreatic Neoplasms - diagnosis | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Lung Neoplasms - pathology | Male | Neoplasms, Unknown Primary - diagnosis | Appendiceal Neoplasms - diagnosis | Nasopharyngeal Neoplasms - pathology | Pancreatic Neoplasms - drug therapy | Gastrointestinal Neoplasms - pathology | Appendiceal Neoplasms - drug therapy | Female | Pancreatic Neoplasms - mortality | Chemotherapy, Adjuvant | Nasopharyngeal Neoplasms - drug therapy | Child | Nasopharyngeal Neoplasms - diagnosis | Neoplasms, Unknown Primary - drug therapy | Carcinoid Tumor - drug therapy | Pancreatic Neoplasms - pathology | Survival Rate | Combined Modality Therapy | Gastrointestinal Neoplasms - diagnosis | Neoplasms, Unknown Primary - mortality | Appendiceal Neoplasms - mortality | Disease Progression | Carcinoid Tumor - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Appendiceal Neoplasms - pathology | Carcinoid Tumor - mortality | Lung Neoplasms - diagnosis | Carcinoid Tumor - diagnosis | Germany | Neoplasms, Unknown Primary - pathology
Journal Article
Disease markers, ISSN 0278-0240, 6/2017, Volume 2017, pp. 6570808 - 9
The C-reactive protein/albumin (CRP/Alb) ratio has been recently identified as a prognostic factor in various cancers, whereas its role remains unclear in... 
Pathology | Life Sciences & Biomedicine | Genetics & Heredity | Biotechnology & Applied Microbiology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Bone Neoplasms - mortality | Lung Neoplasms - drug therapy | Predictive Value of Tests | Nasopharyngeal Neoplasms - mortality | Prognosis | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Carcinoma - mortality | Male | Liver Neoplasms - mortality | Nasopharyngeal Neoplasms - pathology | Fluorouracil - therapeutic use | C-Reactive Protein - metabolism | Lung Neoplasms - secondary | Adult | Female | Retrospective Studies | Bone Neoplasms - drug therapy | Nasopharyngeal Neoplasms - drug therapy | Carcinoma - pathology | Liver Neoplasms - secondary | Nasopharyngeal Neoplasms - diagnosis | Carcinoma - drug therapy | Nasopharyngeal Carcinoma | Bone Neoplasms - diagnosis | Liver Neoplasms - drug therapy | Carcinoma - diagnosis | Paclitaxel - therapeutic use | Biomarkers, Tumor - blood | Liver Neoplasms - diagnosis | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | ROC Curve | Aged | Lung Neoplasms - diagnosis | Serum Albumin - metabolism | Care and treatment | C-reactive protein | Analysis | Albumin | Dosage and administration | Genetic aspects | Nasopharyngeal cancer | Research | Metastasis | Cisplatin | Inflammation | Multivariate analysis | Survival | Patients | Metastases | Nasopharyngeal carcinoma | Chemotherapy | Medical prognosis | Hemoglobin | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 5, pp. 1845 - 1850
...) added to the concurrent therapy of weekly paclitaxel/carboplatin (PC) and daily radiation therapy (RT... 
Radiology | Hematology, Oncology and Palliative Medicine | Concurrent cetuximab | Chemoradiation | Locally advanced head and neck cancer | Concurrent chemotherapy | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Oropharyngeal Neoplasms - therapy | Chemoradiotherapy - adverse effects | Head and Neck Neoplasms - virology | Nasopharyngeal Neoplasms - mortality | Prospective Studies | Follow-Up Studies | Area Under Curve | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Oropharyngeal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Oropharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - mortality | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Chemoradiotherapy - methods | ErbB Receptors - antagonists & inhibitors | Drug Administration Schedule | Nasopharyngeal Neoplasms - therapy | Head and Neck Neoplasms - therapy | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Paclitaxel - adverse effects | Oropharyngeal Neoplasms - virology | Papillomaviridae - isolation & purification | Remission Induction | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Laryngeal Neoplasms - mortality | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hypopharyngeal Neoplasms - pathology | Aged | Head and Neck Neoplasms - mortality | Neoplasm Staging | Medical colleges | Care and treatment | Squamous cell carcinoma | Radiation | Clinical trials | Radiotherapy | Antineoplastic agents | Antimitotic agents | Epidermal growth factor | Nuclear radiation | Analysis | Paclitaxel | Cancer | Index Medicus | GROWTH FACTORS | HEAD | PATIENTS | DERMATITIS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | TOXICITY | NECK | RADIOTHERAPY | RECEPTORS | CHEMOTHERAPY
Journal Article
Journal Article